Biodefense

Project BioShield

On July 21, 2004, President Bush signed into law Project BioShield, which provides new tools to improve medical countermeasures protecting Americans against a chemical, biological, radiological, or nuclear (CBRN) attack.

Project BioShield is a comprehensive effort overseen jointly by the Department of Health and Human Services (HHS) and the Department of Homeland Security (DHS), and involving other federal agencies, including NIH, as appropriate. Project BioShield will

• Ensure that resources are available to pay for “next-generation” medical countermeasures
• Expedite the conduct of NIH research and development on medical countermeasures
• Give the Food and Drug Administration (FDA) the ability to make promising treatments quickly available in emergency situations

More information about Project BioShield is provided below. Please check back for updates.

HHS Project BioShield Web Site

Meetings

• HHS Public Health Emergency Medical Countermeasures (PHEMC) Enterprise Stakeholders Workshop—July 31 –  August 2, 2007, Fairmont, Washington DC, 2401 M Street, NW, Washington, DC 20037

News Releases/Fact Sheets

• HHS Fact Sheet—Project BioShield
• President Bush Signs Project BioShield Act of 2004

Legislation

• Project BioShield Act of 2004

Background Information

• President Bush Details Project BioShield, February 3, 2003
• Transcript of President Bush's Remarks on Project BioShield at NIH, February 3, 2003

back to top